tiprankstipranks
Trending News
More News >
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market

Dermata Therapeutics (DRMA) Technical Analysis

Compare
137 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
5Neutral
15Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Dermata Therapeutics’s (DRMA) Moving Averages Convergence Divergence (MACD) indicator is -0.20, suggesting Dermata Therapeutics is a Sell.
Dermata Therapeutics’s (DRMA) 20-Day exponential moving average is 2.25, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Sell.
Dermata Therapeutics’s (DRMA) 50-Day exponential moving average is 2.78, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Sell.

Dermata Therapeutics (DRMA) Pivot Points

Jan 15, 2026, 07:05 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.88
1.97
2.02
2.11
2.16
2.25
2.30
Fibonacci
1.97
2.02
2.05
2.11
2.16
2.19
2.25
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Dermata Therapeutics (DRMA) Moving Averages

Jan 15, 2026, 07:05 AM
Period
Simple
Exponential
MA5
2.10Sell
2.04Sell
MA10
2.13Sell
2.11Sell
MA20
2.19Sell
2.25Sell
MA50
2.66Sell
2.78Sell
MA100
3.81Sell
3.79Sell
MA200
5.63Sell
5.87Sell
Dermata Therapeutics’s (DRMA) 10-Day exponential moving average is 2.11, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Sell.
Dermata Therapeutics’s (DRMA) 100-Day exponential moving average is 3.79, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Sell.
Dermata Therapeutics’s (DRMA) stock price is $2.14 and Dermata Therapeutics’s (DRMA) 50-day simple moving average is 2.66, creating a Sell signal.
Dermata Therapeutics’s (DRMA) stock price is $2.14 and Dermata Therapeutics’s (DRMA) 100-day simple moving average is 3.81, creating a Sell signal.
Dermata Therapeutics’s (DRMA) stock price is $2.14 and Dermata Therapeutics’s (DRMA) 200-day simple moving average is 5.63, creating a Sell signal.

Dermata Therapeutics (DRMA) Technical Indicators

Jan 15, 2026, 07:05 AM
Name
Value
Implied Action
RSI (14)
34.93
Neutral
STOCH (9,6)
33.68
Neutral
STOCHRSI (14)
38.69
Neutral
MACD (12,26)
-0.20
Sell
ADX (14)
21.85
Neutral
Williams %R
-78.57
Buy
CCI (14)
-152.07
Buy
ATR (14)
0.30
-
Ultimate Oscillator
33.15
Neutral
ROC
-14.95
Sell
Dermata Therapeutics’s (DRMA) Relative Strength Index (RSI) is 34.93, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Trend Strength Indicator (ADX) is 21.85, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Commodity Channel Index (CCI) is -152.07, creating a Buy signal.
Dermata Therapeutics’s (DRMA) Price Rate of Change (ROC) is -14.95, creating a Sell signal.

FAQ

Is DRMA a Buy, Hold, or Sell?
Based on DRMA’s technical indicators, DRMA is a Strong Sell.
    What is DRMA’s RSI (14)?
    DRMA’s RSI (14) is 34.93, which suggests DRMA is a Neutral.
      What is DRMA’s MACD?
      DRMA’s MACD is -0.20, which suggests DRMA is a Sell.
        What is DRMA’s 5-day moving average?
        DRMA’s 5-day moving average is 2.10, which suggests DRMA is a Sell.
          What is DRMA’s 20-day moving average?
          DRMA 20-day moving average is 2.19, which suggests DRMA is a Sell.
            What is DRMA’s 50-day moving average?
            DRMA’s 50-day moving average is 2.66, which suggests DRMA is a Sell.
              What is DRMA’s 200-day moving average?
              DRMA’s 200-day moving average is 5.63, which suggests DRMA is a Sell.
                What is DRMA’s Williams % R (14)?
                DRMA’s Williams % R (14) is -78.57, which suggests DRMA is a Buy.
                  What is DRMA’s CCI (14)?
                  DRMA’s CCI (14) is -152.07, which suggests DRMA is a Buy.